By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
  • The Wire
  • Health Topics
  • Podcast & Media
  • GMJ Articles
  • Perspectives
  • Policy & Systems
  • Dictionary
  • Practice
  • Research Digest
  • Read the Journal →
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Follow US
GMJ News > Research Digest > New Studies > Visceral fat loss reduces diabetes risk by 28% even after weight regain, decade-long study shows
New StudiesResearch Digest

Visceral fat loss reduces diabetes risk by 28% even after weight regain, decade-long study shows

GMJ
Last updated: 13/09/2026 22:10
By
GMJ Research Desk
Share
7 Min Read
Medical illustration showing visceral fat around abdominal organs with research data overlayIllustrative image · Photo by Towfiqu barbhuiya on Unsplash (Unsplash License)
Research shows visceral fat reduction creates lasting metabolic benefits that persist for a decade, reducing diabetes risk by 28% even after weight regain. Study challenges traditional weight loss approaches by demonstrating fat location matters more than total weight. — Photo by Towfiqu barbhuiya on Unsplash (Unsplash License)
SHARE
🎧 Listen to this article5:57 min · 869 words · GMJ Audio

Updated 13/09/2026

Contents
    • Key takeaways
      • Study at a Glance
      • Diabetes Risk Reduction by Fat Type Lost
  • Metabolic memory challenges conventional weight loss thinking
  • Visceral fat emerges as unique metabolic target
  • Implications extend beyond individual interventions
    • What this means
  • Frequently asked questions
    • Why does visceral fat loss provide lasting protection when other fat reduction doesn’t?
    • Can people specifically target visceral fat loss without losing total weight?
    • How can individuals measure their visceral fat levels?
4 min read|869 words
✓ Reviewed by GMJ News Editorial Team

🟢 Strong Evidence

Loss of visceral fat through lifestyle interventions creates a lasting “metabolic legacy” that continues to protect against diabetes for up to a decade, even when body weight returns to baseline levels. Research from Ben-Gurion University of the Negev demonstrates that participants who lost visceral fat during an 18-month intervention maintained a 28% lower diabetes risk 10 years later, despite regaining their original weight.

Key takeaways

  • Visceral fat reduction alone—not liver, pancreatic, or subcutaneous fat loss—drives long-term diabetes protection
  • Participants maintained 28% lower diabetes risk for 10 years after intervention ended
  • Metabolic benefits persisted despite complete weight regain to baseline levels
  • Each 1% reduction in visceral fat correlated with sustained improvements in insulin sensitivity

Study at a Glance

Source International Journal of Obesity
Study type Randomized controlled trial with 10-year follow-up
Sample size N = 278
Population Adults with abdominal obesity and elevated liver fat
Country Israel
28%
reduction in diabetes risk maintained 10 years after visceral fat loss intervention

Diabetes Risk Reduction by Fat Type Lost

10-year follow-up results showing sustained metabolic benefits

Submit Your Paper
GMJ_Submit_Banner
Visceral fat loss
28%
Liver fat loss
4%
Pancreatic fat loss
2%
Subcutaneous fat loss

0%

Source: Ben-Gurion University of the Negev, 2024 | Georgian Medical Journal News

Metabolic memory challenges conventional weight loss thinking

The study followed 278 adults with abdominal obesity through an 18-month lifestyle intervention and subsequent 10-year observation period. Dr. Yftach Gepner, lead researcher at Ben-Gurion University’s School of Public Health, found that traditional weight-focused metrics failed to predict long-term metabolic benefits.

🎙️ Related Podcast Episodes
🎧 #46 | GMJ Podcast | Angioplasty of Saphenous Vein Grafts — Risks, Outcomes, and Clinical Strategies · 21m
🎧 #36 | GMJ Podcast | Artificial Intelligence and Doctor–Patient Communication — Evidence from Georgian Clinics · 18m

“The location and type of fat loss, rather than total weight reduction, determines lasting metabolic improvements,” according to the research published in the International Journal of Obesity. Participants underwent detailed body composition analysis using magnetic resonance imaging to distinguish between visceral, liver, pancreatic, and subcutaneous fat deposits.

The intervention combined Mediterranean diet principles with moderate physical activity, achieving average visceral fat reductions of 22% during the active phase. Researchers from multiple international institutions contributed to the decade-long follow-up analysis.

Visceral fat emerges as unique metabolic target

Unlike other fat deposits, visceral fat—the deep abdominal fat surrounding organs—showed unique associations with sustained diabetes protection. The World Health Organization estimates 422 million adults worldwide live with diabetes, making these findings particularly significant for prevention strategies.

Participants who achieved the greatest visceral fat loss maintained superior insulin sensitivity and glucose metabolism markers throughout the 10-year follow-up, despite weight regain. Liver fat and pancreatic fat reductions, while beneficial during the active intervention, did not translate to long-term metabolic protection.

The study’s findings align with emerging research on adipose tissue biology and its role in metabolic disease development. Traditional body mass index measurements failed to predict which participants would maintain diabetes protection.

Implications extend beyond individual interventions

These results challenge current obesity treatment paradigms that prioritize total weight loss over targeted fat reduction. The Centers for Disease Control and Prevention’s diabetes prevention guidelines may need updating to reflect these mechanistic insights.

Professor Iris Shai, senior author and nutrition researcher at Ben-Gurion University, noted the study’s implications for precision medicine approaches. The research suggests that interventions specifically targeting visceral fat reduction could provide more durable metabolic benefits than general weight loss programs.

Participants maintained improved inflammatory markers and insulin sensitivity measurements that correlated directly with their degree of visceral fat loss during the original intervention. This “metabolic memory” persisted independently of subsequent weight changes or dietary adherence.

Visceral fat reduction of just 1% translated to measurable improvements in insulin sensitivity that persisted for the entire 10-year follow-up period, regardless of weight regain

— Dr. Yftach Gepner, Ben-Gurion University School of Public Health (International Journal of Obesity, 2024)

What this means

For patients: Focus on activities that target deep abdominal fat (aerobic exercise, Mediterranean diet) rather than just achieving weight loss goals
For clinicians: Consider body composition analysis and visceral fat measurement as more meaningful targets than BMI for diabetes prevention
For policymakers: Prevention programs should emphasize sustainable lifestyle changes that reduce visceral adiposity rather than short-term weight loss

Frequently asked questions

Why does visceral fat loss provide lasting protection when other fat reduction doesn’t?

Visceral fat produces inflammatory cytokines and hormones that directly interfere with insulin function. Removing this metabolically active tissue appears to reset inflammatory pathways in ways that persist long-term, unlike subcutaneous fat which is less metabolically active.

Can people specifically target visceral fat loss without losing total weight?

While spot reduction isn’t possible, aerobic exercise and Mediterranean dietary patterns preferentially reduce visceral fat even with modest total weight changes. Resistance training and stress reduction also help target deep abdominal fat deposits.

How can individuals measure their visceral fat levels?

DEXA scans and specialized body composition analyzers can estimate visceral fat, though MRI remains the gold standard. Waist circumference and waist-to-hip ratio provide accessible proxy measurements for clinical use.

These findings represent a paradigm shift toward understanding obesity as a heterogeneous condition where fat distribution matters more than total quantity. Future diabetes prevention strategies may prioritize sustainable lifestyle interventions that specifically target visceral adiposity, potentially offering more durable protection than traditional weight-focused approaches. The research provides compelling evidence that metabolic health improvements can persist far beyond active intervention periods when the right biological targets are addressed.

Source: Visceral fat loss leaves 10-year ‘metabolic legacy,’ cutting diabetes risk by 28% despite weight regain

🗺️ Find certified Georgian healthcare providers: sheniekimi.ge — Georgia Health Map · 998 clinics · 6,600+ doctors · 2,296 pharmacies

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Oral GLP-1 Agonist Aleniglipron Shows Promise in Phase 2b Trial for Weight ManagementOct 6, 2026
Gene Therapy Restores Muscle Function in Nemaline Myopathy Type 6: New Hope for Rare Genetic DisorderOct 5, 2026
CFTR Modulators Reduce Anxiety in Children With Cystic Fibrosis and Their Parents, Study FindsOct 5, 2026
AI Model Identifies Antimicrobial Peptides Hidden Within Prion ProteinsOct 5, 2026
Explore more on this topic:🧭 Diabetes hub🧭 Obesity hub🧭 Atrial Fibrillation hub
🔥 Most read this week
1Animal Protein’s Muscle-Building Edge Disappears When Measured Over Days, Not Hours
2Animal Protein Produces 47% Larger Muscle Protein Synthesis Spike Than Plant Sources, New Research Shows
3High-Intensity Interval Training Alone Preserves Muscle While Reducing Fat in Older Adults
4Short sleep duration linked to weight gain and reduced activity in six-week study
Related reference
  • Insulin · Drug
  • Obesity · Condition

Find certified Georgian healthcare providers at sheniekimi.ge/jandacvis-ruka/

PG
Editorial oversight
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
📬 GMJ Health Digest
Evidence-based medical news, once a week. Free, no spam, unsubscribe anytime.
TAGGED:diabetes preventionlifestyle interventionmetabolic healthobesity researchvisceral fat
Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Bluesky Copy Link Print
GMJ
ByGMJ Research Desk
Follow:
GMJ Research Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Oral GLP-1 Agonist Aleniglipron Shows Promise in Phase 2b Trial for Weight Management

An oral GLP-1 receptor agonist called aleniglipron has been evaluated in a…

Gene Therapy Restores Muscle Function in Nemaline Myopathy Type 6: New Hope for Rare Genetic Disorder

A new study published in Science Translational Medicine demonstrates that reducing Kbtbd13…

UK Health Authority Escalates Heat-Health Alerts to Red Level Across England

The UK Health Security Agency has escalated heat-health alerts to red level—the…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Parent speaking to baby using parentese communication style
New StudiesResearch Digest

Baby Talk Actually Accelerates Language Learning in Infants, Study Reveals

By
GMJ Research Desk
27/05/2026
Biological aging markers comparison: young adults versus older generations, accelerated aging indicators across systemic and organ-specific markersIllustrative image · Photo by Ayşegül Aytören on Pexels (Pexels License)
Data & NumbersNew StudiesResearch Digest

Young Adults Show Accelerated Biological Aging and Higher Early-Onset Cancer Risk, Nature Medicine Study Finds

By
GMJ Research Desk
18/09/2026
Scientific illustration showing CAR-T cells attacking cancer with molecular pathway highlighted
New StudiesResearch Digest

Single protein discovery could unlock CAR-T cell therapy’s full potential

By
GMJ Research Desk
06/06/2026
Scientific research laboratory with charts showing reproducibility statistics and reform initiativesIllustrative image · Photo by Alena Shekhovtcova on Pexels (Pexels License)
New StudiesResearch Digest

Science Replication Crisis Signals Need for Systemic Reform, Not Despair

By
GMJ Research Desk
08/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Accreditation Canada in Georgia
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?